BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 31511824)

  • 1. Recent Advances in the Pharmacological Activities of Dioscin.
    Yang L; Ren S; Xu F; Ma Z; Liu X; Wang L
    Biomed Res Int; 2019; 2019():5763602. PubMed ID: 31511824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dioscin: A diverse acting natural compound with therapeutic potential in metabolic diseases, cancer, inflammation and infections.
    Tao X; Yin L; Xu L; Peng J
    Pharmacol Res; 2018 Nov; 137():259-269. PubMed ID: 30315966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dioscin: A review on pharmacological properties and therapeutic values.
    Bandopadhyay S; Anand U; Gadekar VS; Jha NK; Gupta PK; Behl T; Kumar M; Radha ; Shekhawat MS; Dey A
    Biofactors; 2022 Jan; 48(1):22-55. PubMed ID: 34919768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dioscin, a natural steroid saponin, induces apoptosis and DNA damage through reactive oxygen species: a potential new drug for treatment of glioblastoma multiforme.
    Lv L; Zheng L; Dong D; Xu L; Yin L; Xu Y; Qi Y; Han X; Peng J
    Food Chem Toxicol; 2013 Sep; 59():657-69. PubMed ID: 23871826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of monomethylated dioscin derivatives and their antitumor activities.
    Li M; Han X; Yu B
    Carbohydr Res; 2003 Jan; 338(2):117-21. PubMed ID: 12526835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in study of dioscin--a natural product].
    Xu LN; Wei YL; Peng JY
    Zhongguo Zhong Yao Za Zhi; 2015 Jan; 40(1):36-41. PubMed ID: 25993784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dioscin and diosgenin: Insights into their potential protective effects in cardiac diseases.
    Li X; Liu S; Qu L; Chen Y; Yuan C; Qin A; Liang J; Huang Q; Jiang M; Zou W
    J Ethnopharmacol; 2021 Jun; 274():114018. PubMed ID: 33716083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analogues of diosgenyl saponins: synthesis and anticancer activity.
    Kaskiw MJ; Tassotto ML; Mok M; Tokar SL; Pycko R; Th'ng J; Jiang ZH
    Bioorg Med Chem; 2009 Nov; 17(22):7670-9. PubMed ID: 19819703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of bidesmosidic dihydrodiosgenin saponins bearing a 3-O-beta-chacotriosyl moiety.
    Zhang Y; Li Y; Zhu S; Guan H; Lin F; Yu B
    Carbohydr Res; 2004 Jul; 339(10):1753-9. PubMed ID: 15220085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solanum incanum and S. heteracanthum as sources of biologically active steroid glycosides: confirmation of their synonymy.
    Manase MJ; Mitaine-Offer AC; Pertuit D; Miyamoto T; Tanaka C; Delemasure S; Dutartre P; Mirjolet JF; Duchamp O; Lacaille-Dubois MA
    Fitoterapia; 2012 Sep; 83(6):1115-9. PubMed ID: 22579841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dioscin (saponin)-induced generation of reactive oxygen species through mitochondria dysfunction: a proteomic-based study.
    Wang Y; Che CM; Chiu JF; He QY
    J Proteome Res; 2007 Dec; 6(12):4703-10. PubMed ID: 17975908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dioscin alleviates lipopolysaccharide-induced inflammatory kidney injury via the microRNA let-7i/TLR4/MyD88 signaling pathway.
    Qi M; Yin L; Xu L; Tao X; Qi Y; Han X; Wang C; Xu Y; Sun H; Liu K; Peng J
    Pharmacol Res; 2016 Sep; 111():509-522. PubMed ID: 27431331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dioscin ameliorates cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via HMGB-1 inhibition.
    Tao X; Sun X; Yin L; Han X; Xu L; Qi Y; Xu Y; Li H; Lin Y; Liu K; Peng J
    Free Radic Biol Med; 2015 Jul; 84():103-115. PubMed ID: 25772012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dioscin ameliorates intestinal ischemia/reperfusion injury via adjusting miR-351-5p/MAPK13-mediated inflammation and apoptosis.
    Zheng L; Han X; Hu Y; Zhao X; Yin L; Xu L; Qi Y; Xu Y; Han X; Liu K; Peng J
    Pharmacol Res; 2019 Jan; 139():431-439. PubMed ID: 30503840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation.
    Zhang Y; Xu Y; Qi Y; Xu L; Song S; Yin L; Tao X; Zhen Y; Han X; Ma X; Liu K; Peng J
    Toxicology; 2017 Mar; 378():53-64. PubMed ID: 28082111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin.
    Raju J; Mehta R
    Nutr Cancer; 2009; 61(1):27-35. PubMed ID: 19116873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dioscin induced activation of p38 MAPK and JNK via mitochondrial pathway in HL-60 cell line.
    Wang Y; He QY; Chiu JF
    Eur J Pharmacol; 2014 Jul; 735():52-8. PubMed ID: 24755146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion.
    Lim WC; Kim H; Kim YJ; Choi KC; Lee IH; Lee KH; Kim MK; Ko H
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3342-3348. PubMed ID: 28610976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
    Yin L; Zheng L; Xu L; Dong D; Han X; Qi Y; Zhao Y; Xu Y; Peng J
    BMC Complement Altern Med; 2015 Mar; 15():41. PubMed ID: 25879470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, cytotoxicity, and hemolytic activity of 6'-O-substituted dioscin derivatives.
    Li W; Qiu Z; Wang Y; Zhang Y; Li M; Yu J; Zhang L; Zhu Z; Yu B
    Carbohydr Res; 2007 Dec; 342(18):2705-15. PubMed ID: 17945208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.